1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with nip 121 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aida, M; Igarashi, T; Kaneko, H; Mochizuki, Y; Shigenobu, K; Tanaka, H; Tanaka, Y; Taniguchi, H; Yamaki, F | 1 |
1 other study(ies) available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and nip 121
| Article | Year |
|---|---|
NO-mediated MaxiK(Ca) channel activation produces relaxation of guinea pig aorta independently of voltage-dependent L-type Ca(2+) channels.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Calcium Channel Blockers; Calcium Channels, L-Type; Drug Interactions; Female; Guinea Pigs; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Male; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Nitroarginine; Norepinephrine; Oxadiazoles; Peptides; Piperidines; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Chloride; Quinoxalines; Vasodilation | 2000 |